The bottom line: microneedle patches are real science with real promise, but the earliest any could reach consumers is roughly 2028 to 2030
While short-term side effects like vertigo, increased body temperature, mood swings, and nausea can occur, long-term side effects are less well-documented due to limited research
Before starting any GLP-1 pathway protocol, the Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights, including variants in FTO and MC4R, and TCF7L2 that shape your baseline GLP-1, appetite-regulation, and energy-balance biology
Gupta AK, Talukder M, Venkataraman M, Bamimore MA
Phase 2 Trial of Retatrutide for Obesity
2020;7:e575e582